FDA — authorised 2 February 2010
- Application: BLA125338
- Marketing authorisation holder: AUXILIUM PHARMS
- Status: supplemented
FDA authorised XIAFLEX on 2 February 2010
Yes. FDA authorised it on 2 February 2010.
AUXILIUM PHARMS holds the US marketing authorisation.